Ad
Ad
Ad
Short

According to Reuters, the United States is preparing new export regulations for AI chips that would position companies like Google and Microsoft as global gatekeepers for access to this technology outside the US. The companies would need to meet strict requirements, including reporting key information to the US government and blocking Chinese access to AI chips. In exchange, they could offer AI capabilities in the cloud abroad without requiring a license. Other companies would compete for licenses to obtain a limited number of high-end chips from Nvidia and AMD in each country. The rules would exempt 19 allied countries and Taiwan from these caps, while countries under nuclear embargoes like Russia and China would remain blocked. The regulations might face resistance from some countries. Industry representatives worry that the Biden administration is rushing to implement these complex rules without input from the sector.

Ad
Ad
Short

Chinese state television reports that China has opened an antitrust investigation into US chipmaker Nvidia. The investigation focuses on Nvidia's acquisition of Israeli networking company Mellanox, which China approved in 2020, marking the latest escalation in the US-China technology conflict. The probe comes after the US recently imposed new restrictions on memory chip sales to China. China responded by banning exports of critical chip materials like germanium and gallium. Nvidia, valued at over $3 trillion, is the world's second most valuable company and the leading supplier of AI chips. The company's stock dropped nearly 2 percent in premarket trading. Both countries are heavily investing in domestic chip production, with the US funding the CHIPS Act and China creating a new $47.5 billion state fund.

Short

A study by the Radiological Society of North America (RSNA) shows that AI-assisted mammography can enhance early cancer detection. More than one-third of women at ten medical practices opted to pay for AI screening programs themselves. The AI-supported examinations found 21 percent more cancer cases compared to standard screenings. In the AI-supported version, FDA-approved software analyzes the mammograms. An expert reviews cases where the AI and the first examiner reach different conclusions. Among 747,604 examined women, those who participated in AI screening showed a 43 percent higher detection rate—21 percent from the AI itself, and 22 percent because more high-risk patients signed up. The researchers presented their findings at the RSNA annual meeting. According to the team, the data indicates that many women want to use AI to improve their screening results, and that combining AI with safety verification leads to higher cancer detection rates.

Ad
Ad
Google News